ShareValue scores for SIGA: Valuation 51, Quality 69, Growth 47, Health 66.
SIGANASDAQ
SIGA Technologies Inc
$2.97
(-5.71%)
Updated
SIGANASDAQ
SIGA Technologies Inc
$2.97(-5.71%)
Updated
Loading chart...
Sentiment
Pulse
Value:Fair Value vs US-listed small-cap Healthcare stocks
Quality:Moderate
Growth:Moderate
Health:Moderate
Pulse
Fundamental Rating
Moderate
Value Trap Risk
If P/E met sector median
Not enough data
Rating
Moderate
Trap Risk
P/E to median
Not enough data
Valuation
51
Fair Value
vs US-listed small-cap Healthcare stocks
Price vs Value
Quality
69
Moderate
Business Strength
Growth
47
Moderate
Revenue & Earnings
Health
66
Moderate
Financial Stability
Price trend
38
Weak
Separate from the four scores
Company Details
About
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States. The company's lead product is TPOXX, an antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. was incorporated in 1995 and is headquartered in New York, New York.
Market Cap$213M
P/E RatioN/A
Dividend YieldNone
Sector Rank#645
Score Analysis
AI Investment Thesis
Data as of:Nov 6, 2026